title: [Visceral and thoracic surgical interventions in patients over 80 years old. Evaluation of cost coverage].
abstract: Due to the higher incidence of malignant tumours with increasing age, cancer is the second most common cause of death among those aged over 65 years old. Consequently, demographic changes in Germany have resulted in a rising demand for oncological operations in elderly patients which is more cost-intensive. Objective of the present study in the setting of a university surgical department is whether oncological operations on patients over 80 years old is cost-effective in the era of diagnosis-related groups. The revenue and expenditure of 116 cases of patients over 80 years old documented for the years 2005-2007 were collated and evaluated. The calculated average proceeds were compared with cases of patients under 80 years old.The average return was -1493.50 EUR/case for over 80-year olds and was not cost-effective. The presence or absence of complications had a significant impact on proceeds, because the mean return/case without complications was profitable (1297.30 EUR). Medical care of patients over 80 years old was on average cost-effective and generated a profit. Oncological operations in patients under 80 years old were not sufficiently remunerated by the current DRG system. Therefore, there is an economical risk associated with oncological operations in elderly patients.
authors.affiliation: Chirurgische Klinik und Poliklinik der Ludwig-Maximilians-Universität München, Campus Grosshadern, München. Florian.Loehe@klinikum-landshut.de
authors.forename: F
authors.initials: F
authors.lastname: Löhe
authors.forename: H M
authors.initials: HM
authors.lastname: Hornung
authors.forename: K-W
authors.initials: KW
authors.lastname: Jauch
authors.forename: M K
authors.initials: MK
authors.lastname: Angele
mesh_terms: D000008:Abdominal Neoplasms / Q000191:economics* / Q000401:mortality / Q000601:surgery*; D000368:Aged; D000369:Aged, 80 and over; D015897:Comorbidity; D003362:Cost-Benefit Analysis / Q000191:economics; D003365:Costs and Cost Analysis; D003953:Diagnosis-Related Groups / Q000191:economics*; D005858:Germany; D017721:Hospital Costs / Q000706:statistics & numerical data; D017052:Hospital Mortality; D006801:Humans; D007362:Intensive Care Units / Q000191:economics; D007902:Length of Stay / Q000191:economics; D009313:National Health Programs / Q000191:economics*; D011183:Postoperative Complications / Q000191:economics; D012051:Reimbursement Mechanisms / Q000191:economics; D013899:Thoracic Neoplasms / Q000191:economics* / Q000401:mortality / Q000601:surgery*
references.citation: J Thorac Cardiovasc Surg. 1997 Jan;113(1):37-49
references.pmid: 9011700
references.citation: BMJ. 2008 Dec 09;337:a2467
references.pmid: 19066258
references.citation: Chirurg. 2007 Aug;78(8):748-56
references.pmid: 17646947
references.citation: J Surg Oncol. 2001 Jun;77(2):115-22
references.pmid: 11398165
references.citation: J Surg Oncol. 2006 Mar 1;93(3):173-80
references.pmid: 16482596
references.citation: Dis Colon Rectum. 2004 Jul;47(7):1225-31
references.pmid: 15164247
references.citation: Dtsch Med Wochenschr. 2005 Feb 18;130(7):351-2
references.pmid: 15712025
references.citation: Cancer. 2008 Dec 15;113(12 Suppl):3493-504
references.pmid: 19058150
references.citation: Tumori. 2007 Sep-Oct;93(5):478-84
references.pmid: 18038881
references.citation: Ann Surg. 2006 Aug;244(2):254-9
references.pmid: 16858188
references.citation: Clin Oncol (R Coll Radiol). 2009 Mar;21(2):92-8
references.pmid: 19059768
references.citation: Eur J Cardiothorac Surg. 2007 Sep;32(3):445-8
references.pmid: 17643999
references.citation: Schweiz Med Wochenschr. 1981 Sep 5;111(36):1309-13
references.pmid: 7302534
references.citation: Lung Cancer. 2008 Nov;62(2):221-7
references.pmid: 18433928
references.citation: Chirurg. 2005 Jan;76(1):28-34
references.pmid: 15551008